HomeIndustriesHealthcareJNJ Pharmaceuticals Shine, Drug Pipeline & Talc Lawsuit Settlement Linger
00:00
00:00
05:41
JNJ Pharmaceuticals Shine, Drug Pipeline & Talc Lawsuit Settlement Linger

JNJ Pharmaceuticals Shine, Drug Pipeline & Talc Lawsuit Settlement Linger

Johnson & Johnson (JNJ) posted notable strengths in their earnings Tuesday. Jeff Jonas points to the company's pharmaceuticals sector as the highlight, arguing the company has a great pipeline which can withstand tariffs. One overhang: the company's talc lawsuit. Jeff thinks Johnson & Johnson paying the $10 billion settlement is the best route it can make to move forward.

Trading 360

15 Apr 2025

SHARE

ON AIR
1:00 pm
Morning Trade Live
education
5:00 am
Your First Trade
REPLAY
education
5:30 am
Your First Trade
REPLAY
6:00 am
The Wrap
REPLAY
7:00 am
Fast Market
REPLAY
8:00 am
Next Gen Investing
REPLAY
9:00 am
Market Overtime
REPLAY
education
9:30 am
Inside the Mind of a Trader
REPLAY
education
10:00 am
Inside the Mind of a Trader
REPLAY
education
10:30 am
Inside the Mind of a Trader
REPLAY
11:00 am
Market Overtime
REPLAY
12:00 pm
Morning Movers
ON AIR
1:00 pm
Morning Trade Live
3:00 pm
Trading 360
4:00 pm
Fast Market
5:00 pm
Next Gen Investing
6:00 pm
The Watch List
7:00 pm
Market On Close
8:30 pm
Market Overtime
REPLAY
9:00 pm
Fast Market
REPLAY
10:00 pm
Next Gen Investing
REPLAY
11:00 pm
The Wrap
REPLAY
12:00 am
Market Overtime
REPLAY
12:30 am
Market Overtime
REPLAY
1:00 am
The Wrap
REPLAY
2:00 am
Market Overtime
REPLAY
3:00 am
Fast Market
REPLAY
4:00 am
Next Gen Investing
REPLAY

Schwab Network's Newsletters

Daily insights for every investor